Drug delivery device refers to various technologies used to transport pharmaceutical compounds in the body. Effective drug delivery ensures availability of right concentrations of active pharmaceutical ingredients at the site of action. It helps improve efficacy of drugs and patient compliance. Rapid developments in biologics, personalized medicine and increasing prevalence of chronic diseases can boost demand for advanced drug delivery systems. Constant innovations in drug delivery devices focused on enhancing safety, precision and ease-of-use can drive the market growth in the near future.
Global drug delivery device market growth is driven by rising incidence of chronic illnesses such as diabetes, cancer and cardiovascular diseases. Growing geriatric population and increasing healthcare spending also drives the market growth. However, high costs associated with development of advanced delivery systems can hamper the market growth. Regulatory hurdles for innovative products can also hamper the market growth. Emerging economies offer lucrative opportunities for market players. Escalating demand for self-administered injection devices and home healthcare can offer market growth opportunities. Continued technological advancements in portable and wearable delivery systems can also offer growth opportunities. Adoption of smart devices enabled with internet of things is a key trend in the market.
- This report provides in-depth analysis of the global drug delivery device market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global drug delivery device market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Becton, Dickinson and Company, Baxter International, Pfizer, Gerresheimer, and Nemera.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global drug delivery device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug delivery device market.
-
- Oral
- Parenteral
- Transdermal
- Ocular
- Pulmonary
-
- Oncology
- Infectious Diseases
- Respiratory Diseases
- Diabetes
- Cardiovascular Diseases
- Autoimmune Diseases
- Central Nervous System Disorders
-
- Hospitals
- Diagnostic Centers
- Ambulatory Surgery Centers/Clinics
- Home Care Settings
- Others
-
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
-
- Abbott Laboratories
- Adherium Ltd.
- Amiko Digital Health Limited
- Becton, Dickinson and Company
- BIOCORP
- CeQur Corporation
- Cognita Labs
- E3D Elcam Drug Delivery Devices
- H&T Presspart Manufacturing Ltd.
- HCmed Innovations Co., Ltd.
- Medtronic plc
- Novo Nordisk A/S
- Phillips-Medisize
- Sonceboz
- Enable Injections, Inc.
- NOVO Engineering
- Elcam Medical
- Battelle
- Gerresheimer AG
- Aphios
